These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22184057)

  • 1. Role of mineralocorticoid receptor/Rho/Rho-kinase pathway in obesity-related renal injury.
    Tokuyama H; Wakino S; Hara Y; Washida N; Fujimura K; Hosoya K; Yoshioka K; Hasegawa K; Minakuchi H; Homma K; Hayashi K; Itoh H
    Int J Obes (Lond); 2012 Aug; 36(8):1062-71. PubMed ID: 22184057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial mineralocorticoid receptor activation mediates endothelial dysfunction in diet-induced obesity.
    Schäfer N; Lohmann C; Winnik S; van Tits LJ; Miranda MX; Vergopoulos A; Ruschitzka F; Nussberger J; Berger S; Lüscher TF; Verrey F; Matter CM
    Eur Heart J; 2013 Dec; 34(45):3515-24. PubMed ID: 23594590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Rho kinase and oxidative stress in cardiac fibrosis induced by aldosterone and salt in angiotensin type 1a receptor knockout mice.
    Kagiyama S; Matsumura K; Goto K; Otsubo T; Iida M
    Regul Pept; 2010 Feb; 160(1-3):133-9. PubMed ID: 19969025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rho kinase pathway is likely responsible for the profibrotic actions of aldosterone in renal epithelial cells via inducing epithelial-mesenchymal transition and extracellular matrix excretion.
    Wei J; Li Z; Ma C; Zhan F; Wu W; Han H; Huang Y; Li W; Chen D; Peng Y
    Cell Biol Int; 2013 Jul; 37(7):725-30. PubMed ID: 23456826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eplerenone prevented obesity-induced inflammasome activation and glucose intolerance.
    Wada T; Ishikawa A; Watanabe E; Nakamura Y; Aruga Y; Hasegawa H; Onogi Y; Honda H; Nagai Y; Takatsu K; Ishii Y; Sasahara M; Koya D; Tsuneki H; Sasaoka T
    J Endocrinol; 2017 Dec; 235(3):179-191. PubMed ID: 28855315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldosterone induces myofibroblastic transdifferentiation and collagen gene expression through the Rho-kinase dependent signaling pathway in rat mesangial cells.
    Diah S; Zhang GX; Nagai Y; Zhang W; Gang L; Kimura S; Hamid MR; Tamiya T; Nishiyama A; Hitomi H
    Exp Cell Res; 2008 Dec; 314(20):3654-62. PubMed ID: 18929559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of aldosterone on diet-induced fatty liver formation in male C57BL/6 mice: comparison of adrenalectomy and mineralocorticoid receptor blocker.
    Gamliel-Lazarovich A; Raz-Pasteur A; Coleman R; Keidar S
    Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1086-92. PubMed ID: 23524523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor: role of oxidative stress.
    Nagase M; Matsui H; Shibata S; Gotoda T; Fujita T
    Hypertension; 2007 Nov; 50(5):877-83. PubMed ID: 17875821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1.
    Shibata S; Nagase M; Yoshida S; Kawachi H; Fujita T
    Hypertension; 2007 Feb; 49(2):355-64. PubMed ID: 17200434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldosterone stimulates nuclear factor-kappa B activity and transcription of intercellular adhesion molecule-1 and connective tissue growth factor in rat mesangial cells via serum- and glucocorticoid-inducible protein kinase-1.
    Terada Y; Ueda S; Hamada K; Shimamura Y; Ogata K; Inoue K; Taniguchi Y; Kagawa T; Horino T; Takao T
    Clin Exp Nephrol; 2012 Feb; 16(1):81-8. PubMed ID: 22042038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Inhibitory Effect of Eplerenone on Cell Proliferation in the Contralateral Kidneys of Rats with Unilateral Ureteral Obstruction.
    Wang CH; Wang Z; Liang LJ; Wang XT; Ma XL; Liu BB; He JQ; Shimosawa T; Xu QY
    Nephron; 2017; 136(4):328-338. PubMed ID: 28402979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eplerenone shows renoprotective effect by reducing LOX-1-mediated adhesion molecule, PKCepsilon-MAPK-p90RSK, and Rho-kinase pathway.
    Kobayashi N; Hara K; Tojo A; Onozato ML; Honda T; Yoshida K; Mita S; Nakano S; Tsubokou Y; Matsuoka H
    Hypertension; 2005 Apr; 45(4):538-44. PubMed ID: 15710785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial natriuretic peptide locally counteracts the deleterious effects of cardiomyocyte mineralocorticoid receptor activation.
    Nakagawa H; Oberwinkler H; Nikolaev VO; Gaßner B; Umbenhauer S; Wagner H; Saito Y; Baba HA; Frantz S; Kuhn M
    Circ Heart Fail; 2014 Sep; 7(5):814-21. PubMed ID: 25027872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotective mechanisms of spironolactone associated with the angiotensin-converting enzyme/epidermal growth factor receptor/extracellular signal-regulated kinases, NAD(P)H oxidase/lectin-like oxidized low-density lipoprotein receptor-1, and Rho-kinase pathways in aldosterone/salt-induced hypertensive rats.
    Nakano S; Kobayashi N; Yoshida K; Ohno T; Matsuoka H
    Hypertens Res; 2005 Nov; 28(11):925-36. PubMed ID: 16555582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible underlying mechanisms responsible for aldosterone and mineralocorticoid receptor-dependent renal injury.
    Kiyomoto H; Rafiq K; Mostofa M; Nishiyama A
    J Pharmacol Sci; 2008 Dec; 108(4):399-405. PubMed ID: 19057124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors.
    Nagase M; Yoshida S; Shibata S; Nagase T; Gotoda T; Ando K; Fujita T
    J Am Soc Nephrol; 2006 Dec; 17(12):3438-46. PubMed ID: 17082236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-Dose Mineralocorticoid Receptor Blockade Prevents Western Diet-Induced Arterial Stiffening in Female Mice.
    DeMarco VG; Habibi J; Jia G; Aroor AR; Ramirez-Perez FI; Martinez-Lemus LA; Bender SB; Garro M; Hayden MR; Sun Z; Meininger GA; Manrique C; Whaley-Connell A; Sowers JR
    Hypertension; 2015 Jul; 66(1):99-107. PubMed ID: 26015449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eplerenone ameliorates the phenotypes of metabolic syndrome with NASH in liver-specific SREBP-1c Tg mice fed high-fat and high-fructose diet.
    Wada T; Miyashita Y; Sasaki M; Aruga Y; Nakamura Y; Ishii Y; Sasahara M; Kanasaki K; Kitada M; Koya D; Shimano H; Tsuneki H; Sasaoka T
    Am J Physiol Endocrinol Metab; 2013 Dec; 305(11):E1415-25. PubMed ID: 24129399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleiotropic actions of aldosterone and the effects of eplerenone, a selective mineralocorticoid receptor antagonist.
    Takeda Y
    Hypertens Res; 2004 Nov; 27(11):781-9. PubMed ID: 15824460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effects of aldosterone blockade.
    Nishiyama A; Abe Y
    J Pharmacol Sci; 2006 Jan; 100(1):9-16. PubMed ID: 16397374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.